Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of specific KRAS mutations in lung adenocarcinomas.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 1997

Siegfried J M, Gillespie A T, Mera R, Casey T J, Keohavong P, Testa J R, Hunt J D

Abstract excerpt

Adenocarcinomas of the lung remain a significant public health problem. Locally defined (stage I) tumors are considered amenable to resection with curative intent. However, only about 45% of these patients survive for 5 years. The median survival for more advanced tumors is drastically lower. Much research has been focused on identifying a valid genetic biomarker of prognosis. Mutations of the proto-oncogene KRAS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Electrophoresis, Polyacrylamide Gel

Share to Genes, ras

Share to Lung Neoplasms

Share to Mutation

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9332768

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of specific KRAS mutations in lung adenocarcinomas.PMID 9332768Read ↗

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.Semantic proximity Read ↗

The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma.Semantic proximity Read ↗

Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features.Semantic proximity Read ↗

KRAS Mutations in Squamous Cell Carcinomas of the LungSemantic proximity Read ↗

KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma.Semantic proximity Read ↗

KRAS codon 12 mutations in Australian non-small cell lung cancer.Semantic proximity Read ↗

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.Semantic proximity Read ↗

Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features.Semantic proximity Read ↗

Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.Semantic proximity Read ↗

KRAS mutation: should we test for it, and does it matter?Semantic proximity Read ↗

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer.Semantic proximity Read ↗

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.